Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Veradigm Inc (MDRX)

Veradigm Inc (MDRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,166,818
  • Shares Outstanding, K 107,640
  • Annual Sales, $ 1,503 M
  • Annual Income, $ 134,440 K
  • EBIT $ 80 M
  • EBITDA $ 256 M
  • 60-Month Beta 0.60
  • Price/Sales 0.59
  • Price/Cash Flow 3.99
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 1.13
  • Most Recent Earnings N/A on 11/07/22
  • Next Earnings Date 01/04/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend 5.230 on 10/13/08
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.9000 +20.45%
on 11/04/24
11.8000 -9.15%
on 11/11/24
+1.4700 (+15.89%)
since 10/25/24
3-Month
8.6500 +23.93%
on 10/08/24
11.8000 -9.15%
on 11/11/24
+1.0200 (+10.52%)
since 08/23/24
52-Week
5.0100 +113.97%
on 03/01/24
12.6550 -15.29%
on 12/06/23
-1.7600 (-14.10%)
since 11/24/23

Most Recent Stories

More News
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Veradigm Inc. - MDRX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX). Such investors are...

MDRX : 10.7200 (-1.11%)
MDRX INVESTIGATION: Robbins Geller Rudman & Dowd LLP Announces Investigation into Veradigm Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

/PRNewswire/ -- Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Veradigm Inc. (NASDAQ: MDRX)...

MDRX : 10.7200 (-1.11%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Veradigm Inc.- MDRX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX). Such investors are...

MDRX : 10.7200 (-1.11%)
Veradigm Joins FDB Vela ePrescribing Network to Offer Prescribers & Patients Greater Choice, Cost Transparency

/PRNewswire/ -- FDB (First Databank, Inc.), a major provider of drug knowledge that helps healthcare professionals make precise decisions, and Veradigm...

MDRX : 10.7200 (-1.11%)
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Veradigm Inc. (MDRX) on Behalf of Investors

/PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM"), a leading national shareholder rights law firm, continues its an investigation on behalf of Veradigm Inc....

MDRX : 10.7200 (-1.11%)
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Veradigm Inc. (MDRX) on Behalf of Investors

/PRNewswire/ -- Law Offices of Howard G. Smith continues its investigation on behalf of Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX) investors...

MDRX : 10.7200 (-1.11%)
The Law Offices of Frank R. Cruz Continues Investigation of Veradigm Inc. (MDRX) on Behalf of Investors

/PRNewswire/ -- The Law Offices of Frank R. Cruz continues its investigation of Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX) on behalf of...

MDRX : 10.7200 (-1.11%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Veradigm Inc.

/PRNewswire/ -- Levi & Korsinsky notifies investors that it has commenced an investigation of Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX)...

MDRX : 10.7200 (-1.11%)
MDRX NEWS: The Klein Law Firm Initiates an Investigation Involving Possible Securities Fraud Violations by Officers of Veradigm Inc.

/PRNewswire/ -- The Klein Law Firm announces that it is investigating allegations that Veradigm Inc. ("Veradigm") (NASDAQ: MDRX) violated federal securities...

MDRX : 10.7200 (-1.11%)
MDRX ALERT: The Law Offices of Vincent Wong Investigate Veradigm Inc. for Potential Violations of Securities Laws

/PRNewswire/ -- Attention Veradigm Inc. ("Veradigm") (NASDAQ: MDRX) shareholders: The Law Offices of Vincent Wong announce that an investigation has commenced...

MDRX : 10.7200 (-1.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 12.2467
2nd Resistance Point 11.7733
1st Resistance Point 11.2467
Last Price 10.7200
1st Support Level 10.2467
2nd Support Level 9.7733
3rd Support Level 9.2467

See More

52-Week High 12.6550
Last Price 10.7200
Fibonacci 61.8% 9.7346
Fibonacci 50% 8.8325
Fibonacci 38.2% 7.9304
52-Week Low 5.0100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar